Increased 17β-hydroxysteroid dehydrogenase type 1 levels in primary cervical cancer

被引:7
|
作者
Tomaszewska, Agata [1 ,2 ]
Roszak, Andrzej [3 ,4 ]
Pawlik, Piotr [5 ]
Sajdak, Stefan [5 ]
Jagodzinski, Pawel Piotr [1 ]
机构
[1] Poznan Univ Med Sci, Dept Biochem & Mol Biol, PL-60781 Poznan, Poland
[2] Poznan Univ Med Sci, Ctr Orthodont Miniimplants, Chair & Clin Maxillofacial Orthoped & Orthodont, PL-60781 Poznan, Poland
[3] Poznan Univ Med Sci, Dept Electroradiol, PL-60781 Poznan, Poland
[4] Greater Poland Canc Ctr, Dept Radiotherapy & Gynecol Oncol, Poznan, Poland
[5] Poznan Univ Med Sci, Div Gynecol Surg, PL-60781 Poznan, Poland
关键词
HSD17B1; Cervical cancer; 17; beta-Estradiol; HUMAN-PAPILLOMAVIRUS TYPE-16; CELL-LINES; SQUAMOUS CARCINOGENESIS; ESTROGEN; EXPRESSION; ESTRADIOL; RISK; E6; 17-BETA-ESTRADIOL; DEHYDROGENASES;
D O I
10.1016/j.biopha.2015.04.018
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Infections with oncogenic human papillomavirus (HPV) strains are recognized as the major risk factor for developing malignant lesions in the uterine cervix. However, several findings have demonstrated cooperation between HPV infection and 17 beta-estradiol (E2) in cervical carcinogenesis. The 17 beta-hydroxysteroid dehydrogenase type 1 (HSD17B1) is the enzyme involved in the transformation of estrone (E1) into E2. In this study, we identified the HSD17B1 transcript and protein in HeLa, SiHa, Ca Ski and C-33A cervical cancer cells. These cells were able to convert E1 to E2 in a time-dependent manner. Moreover, we identified the HSD17B1 transcript and protein in primary cancerous tissues (n = 28) and in histologically unchanged tissues (n = 25). We did not observe significant differences (P = 0.33) between the HSD17B1 transcript levels in cancerous tissues and histologically unchanged tissues. However, we found an overrepresentation of the HSD17B1 protein in cancerous tissues compared with histologically unchanged tissues (P < 0.001). This overrepresentation of the HSD17B1 protein in primary cervical cancerous tissues may be responsible for the local conversion of E1 to E2. (C) 2015 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:179 / 183
页数:5
相关论文
共 50 条
  • [21] siRNA-based breast cancer therapy by suppressing 17β-hydroxysteroid dehydrogenase type I in an optimized xenograft cell and molecular biology model in vivo
    Li, Fang
    Zhu, ZhiHan
    Xue, Man
    He, WanHong
    Zhang, Ting
    Feng, LingLin
    Lin, ShengXiang
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 757 - 766
  • [22] Synthesis and characterization of targeted 17β-hydroxysteroid dehydrogenase type 7 inhibitors
    Sanceau, Jean-Yves
    Maltais, Rene
    Zhou, Ming
    Lin, Sheng-Xiang
    Poirier, Donald
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2024, 242
  • [23] 17β-Hydroxysteroid Dehydrogenase Type 1 Stimulates Breast Cancer by Dihydrotestosterone Inactivation in Addition to Estradiol Production
    Aka, Juliette A.
    Mazumdar, Mausumi
    Chen, Chang-Qing
    Poirier, Donald
    Lin, Sheng-Xiang
    MOLECULAR ENDOCRINOLOGY, 2010, 24 (04) : 832 - 845
  • [24] Development of 17β-hydroxysteroid dehydrogenase type 3 as a target in hormone-dependent prostate cancer therapy
    Ning, Xiaohui
    Yang, Yan
    Deng, Hong
    Zhang, Qihao
    Huang, Yadong
    Su, Zhijian
    Fu, Yongmei
    Xiang, Qi
    Zhang, Shu
    STEROIDS, 2017, 121 : 10 - 16
  • [25] Inhibition of Type 1 17β-Hydroxysteroid Dehydrogenase Impairs the Synthesis of 17β-Estradiol in Endometriosis Lesions
    Delvoux, Bert
    D'Hooghe, Thomas
    Kyama, Cleophas
    Koskimies, Pasi
    Hermans, Rob J. J.
    Dunselman, Gerard A.
    Romano, Andrea
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (01) : 276 - 284
  • [26] Flavonoids and cinnamic acid derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 1
    Brozic, Petra
    Kocbek, Petra
    Sova, Matej
    Kristl, Julijana
    Martens, Stefan
    Adamski, Jerzy
    Gobec, Stanislav
    Rizner, Tea Lanisnik
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 301 (1-2) : 229 - 234
  • [27] Transcriptional regulation of 17β-hydroxysteroid dehydrogenase type 12 by SREBP-1
    Nagasaki, Shuji
    Miki, Yasuhiro
    Akahira, Jun-ichi
    Suzuki, Takashi
    Sasano, Hironobu
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 307 (1-2) : 163 - 168
  • [28] 17β-Hydroxysteroid Dehydrogenase Type 2 Expression Is Induced by Androgen Signaling in Endometrial Cancer
    Hashimoto, Chiaki
    Miki, Yasuhiro
    Tanaka, Sota
    Takagi, Kiyoshi
    Fue, Misaki
    Doe, Zhulanqiqige
    Li, Bin
    Yaegashi, Nobuo
    Suzuki, Takashi
    Ito, Kiyoshi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (04)
  • [29] Transcriptional regulation of type 11 17β-hydroxysteroid dehydrogenase expression in prostate cancer cells
    Rotinen, Mirja
    Villar, Joaquin
    Celay, Jon
    Serrano, Irantzu
    Notario, Vicente
    Encio, Ignacio
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2011, 339 (1-2) : 45 - 53
  • [30] Probing the origins of 17β-hydroxysteroid dehydrogenase type 1 inhibitory activity via QSAR and molecular docking
    Srungboonmee, Kakanand
    Songtawee, Napat
    Monnor, Teerawat
    Prachayasittikul, Virapong
    Nantasenamat, Chanin
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 96 : 231 - 237